Ubusobanuro buhanitse Indwara Yandura Tifoyide Ikizamini

Imikorere ya Clinical Kubizamini bya IgM
Ingero 334 zivuye mu masomo yanduye zapimwe na Tifoyide Antibody Rapid Ikizamini hamwe n’ubucuruzi S. typhi IgM EIA.Kugereranya kubintu byose byerekanwe kumeza ikurikira.

Ibyiyumvo bifitanye isano: 91.2% (76.3% - 98.1%) *
Umwihariko ugereranije: 99.3% (97,6% - 99,9%) *
Ibisobanuro bifatika: 98.5% (96.5% - 99.5%) *
* 95% Intera

Imikorere ya Clinical Kubizamini bya IgG
Ingero 314 zivuye mu masomo yanduye zapimwe na Tifoyide Antibody Rapid Ikizamini hamwe nubucuruzi S. typhi IgG EIA kit.Kugereranya kubintu byose byerekanwe kumeza ikurikira.

Ibyiyumvo bifitanye isano: 92.9% (66.1% - 99.8%) *
Umwihariko ugereranije: 99.3% (97,6% - 99,9%) *
Ibisobanuro bifatika: 99.0% (97.2% - 99.8%) *
* 95% Intera

UKORESHEJWE

Tifoyide Antibody Rapid Test Device ni immunoassay itembera kuruhande rwo kumenya icyarimwe no gutandukanya icyarimwe anti-Salmonella (S. typhi) IgG na IgM mumaraso yabantu yose, serumu cyangwa plasma.Igamije gukoreshwa nk'ikizamini cyo gusuzuma no gufasha mu gusuzuma indwara yanduye S. typhi.Ikigereranyo icyo aricyo cyose gifatika hamwe na Tifoyide Antibody Yihuta Ikizamini kigomba kwemezwa hamwe nubundi buryo bwo kwipimisha.

Ibyiza byacu

1.Kumenyekana nkumushinga wubuhanga buhanitse mubushinwa, ibyemezo byinshi byo gusaba patenti hamwe nuburenganzira bwa software byemejwe
2.Gutanga ibicuruzwa nkuko ubisaba
3.ISO13485, CE, Tegura inyandiko zitandukanye zo kohereza
4. Subiza abakiriya ibibazo mumasaha 24